A Unified Front: Epilepsy Alliance America Spearheads Landmark Call for a National Plan to Transform Epilepsy Care

Washington D.C. – August 25th, 2026 – In a significant stride towards revolutionizing the landscape of epilepsy care and research in the United States, Epilepsy Alliance America (EAA) today proudly announced the publication of a pivotal article in Epilepsy Currents. Titled "A Call to Action: The National Plan for Epilepsy," the peer-reviewed publication outlines a comprehensive, coordinated strategy urgently needed to address the pervasive challenges faced by the 3.4 million Americans living with epilepsy. This landmark article, born from an unprecedented collaboration of leading epilepsy organizations, advocates for a unified national approach to overcome critical gaps in research funding, public awareness, and access to optimal care.

n

The release of this article marks a new chapter in the advocacy for epilepsy, signaling a robust and concerted effort to bring about systemic change. It underscores the collective conviction that despite individual advancements, the fragmented nature of current efforts is insufficient to tackle the multifaceted burden of epilepsy effectively. The proposed National Plan for Epilepsy aims to knit together existing initiatives, identify new priorities, and mobilize resources on a scale commensurate with the condition’s profound impact on individuals, families, and the national healthcare system.

n

"Epilepsy is a complex neurological disorder that demands a unified national response, yet for too long, our efforts have been disparate," stated a spokesperson for Epilepsy Alliance America. "This publication in Epilepsy Currents is not merely an academic exercise; it is a declaration, a roadmap, and a fervent plea for collective action. It represents years of dedicated work, expert consensus, and an unwavering commitment to improving the lives of millions. We are at a critical juncture where the confluence of scientific understanding, technological capabilities, and an energized advocacy community can truly transform the future for those affected by epilepsy."

n

The article meticulously details the current deficiencies in epilepsy care, ranging from diagnostic delays and treatment resistance to the profound psychosocial stigma and economic strain. It argues compellingly that a coordinated national strategy, akin to successful plans for other major health conditions, is essential to accelerate progress, foster innovation, and ensure equitable access to high-quality care across all demographics and geographies.

n

The Genesis of a Movement: A Chronology Towards a National Plan

n

The journey towards "A Call to Action: The National Plan for Epilepsy" is a testament to persistent advocacy, growing scientific understanding, and the increasing recognition of epilepsy as a significant public health challenge. While individual organizations have long championed specific aspects of epilepsy care and research, the concept of a truly national, coordinated plan has evolved over several years, culminating in the collaborative effort now spotlighted by Epilepsy Alliance America.

n

Early Advocacy and Fragmented Efforts (Decades Prior to 2020s): For many years, advocacy for epilepsy patients largely comprised the efforts of individual foundations, research societies, and patient groups. These organizations played crucial roles in funding research, providing patient support, and raising awareness. However, their initiatives, while impactful within their spheres, often operated independently. This led to a landscape where research priorities might not always be perfectly aligned, awareness campaigns could lack national cohesion, and access to care varied significantly based on local resources and specific organizational reach. The lack of a central, unifying vision often meant that progress, though steady, was not as rapid or as universally impactful as advocates desired.

n

The Spark of Collaboration (Early 2020s): The realization that a more integrated approach was necessary began to solidify in the early 2020s. Leaders from various epilepsy organizations started engaging in more frequent and structured dialogues. These discussions were driven by a shared understanding of persistent challenges: stagnant federal research funding compared to other neurological conditions, the enduring stigma surrounding seizures, and glaring disparities in access to specialized care. There was a growing consensus that pooling resources, expertise, and advocacy power could yield exponentially greater results than working in silos.

n

Formation of The Epilepsy Leadership Council (Mid-2020s): A pivotal moment in this chronology was the formal establishment or strengthening of platforms like The Epilepsy Leadership Council. This council, bringing together the heads of major epilepsy organizations, served as a crucial forum for strategic planning and consensus-building. It allowed for a comprehensive assessment of the existing gaps and the identification of shared priorities. This collaborative body became the engine driving the vision for a national plan, fostering an environment where competitive dynamics were set aside in favor of a common mission.

n

Consensus-Building and Framework Development (Late 2020s): The development of the "National Plan for Epilepsy" was an exhaustive process, involving multiple stakeholders. It wasn’t merely about identifying problems but about crafting actionable solutions. This phase included:

n

n
• Literature Reviews: Comprehensive analyses of existing epilepsy research, treatment guidelines, and public health strategies.

n

• Expert Panels: Convening neurologists, neuroscientists, epidemiologists, public health experts, policymakers, and patient advocates to define the core pillars of the plan.

n

• Patient and Caregiver Input: Crucially, the voices of those living with epilepsy and their families were central to shaping the plan, ensuring that the proposed solutions were grounded in lived experience and addressed real-world needs. Surveys, focus groups, and public forums were integral to this process.

n

• Strategic Roadmapping: Developing specific objectives, measurable outcomes, and timelines for implementation across various domains, including research, clinical care, public health, education, and policy advocacy.

n

n

The commitment from diverse partners such as CURE Epilepsy, the American Epilepsy Society (AES), Epilepsies Action Network, Epilepsy Foundation, National Association of Epilepsy Centers (NAEC), Rare Epilepsy Network (REN), and the International League for Epilepsy (ILAE) underscores the broad scientific, clinical, and advocacy backing for this initiative. Each organization brought its unique perspective and strengths to the table, enriching the plan’s scope and feasibility.

n

Publication in Epilepsy Currents (August 2026): The culmination of these efforts is the peer-reviewed publication in Epilepsy Currents. This journal, a highly respected platform in the field of epileptology, provides the ideal venue for disseminating the plan’s vision to a global audience of clinicians and researchers. The publication legitimizes the plan within the scientific community and serves as a powerful call to action for the wider medical and public health sectors. It’s a statement that the epilepsy community has not only identified a critical need but has also coalesced around a concrete, evidence-based strategy to address it.

n

This detailed chronology illustrates that the "National Plan for Epilepsy" is not a spontaneous idea but the natural evolution of decades of advocacy, now infused with an unprecedented spirit of collaboration and strategic foresight. It represents a unified community speaking with one voice, demanding a future where epilepsy is better understood, better treated, and ultimately, better overcome.

n

Unpacking the Imperative: Supporting Data Illuminating Critical Gaps

n

The call for a National Plan for Epilepsy is not merely aspirational; it is rooted in compelling data that reveals profound disparities and unmet needs across the epilepsy community. The article in Epilepsy Currents meticulously details these challenges, underscoring the urgency of a coordinated national strategy.

n

The Scale of the Challenge: 3.4 Million Americans Affected: Epilepsy is one of the most common neurological disorders globally, and in the United States, it affects approximately 3.4 million people. This figure includes both adults and children, making it a condition that impacts individuals across the entire lifespan. To put this into perspective, epilepsy affects more people than multiple sclerosis, Parkinson’s disease, and cerebral palsy combined. The sheer prevalence means that epilepsy has a significant public health footprint, touching countless families and communities nationwide. Yet, despite its widespread impact, public awareness often lags behind other less common conditions, contributing to diagnostic delays and societal misunderstanding.

n

Chronic Underfunding in Research: One of the most critical gaps highlighted is the persistent underfunding of epilepsy research. While conditions like Alzheimer’s disease, Parkinson’s disease, and even some forms of cancer receive billions in federal research dollars annually, epilepsy funding, though present, is disproportionately low relative to its prevalence and burden.

n

n
• Impact on Discovery: This disparity directly hampers the pace of scientific discovery. Breakthroughs in understanding the mechanisms of seizure generation, developing novel anti-seizure medications, and advancing non-pharmacological treatments (like devices and surgical interventions) are slower than they could be.

n

• Therapeutic Lag: Approximately one-third of people with epilepsy continue to experience uncontrolled seizures despite available treatments (known as drug-resistant epilepsy). For these individuals, the quality of life is severely compromised, and the risk of sudden unexpected death in epilepsy (SUDEP) remains a tragic reality. Insufficient research funding means fewer resources dedicated to finding solutions for these intractable cases.

n

• Prevention and Cure: The ultimate goals of preventing epilepsy and finding a cure remain distant without sustained and significant investment in basic, translational, and clinical research.

n

n

Pervasive Awareness Deficit and Stigma: The lack of public understanding about epilepsy is a major barrier to optimal care and social integration.

n

• Misconceptions: Many people still hold outdated or inaccurate beliefs about epilepsy, often associating it with mental illness or supernatural causes. This contributes to fear, misunderstanding, and discrimination.
• Stigma and Discrimination: Individuals with epilepsy frequently face stigma in educational settings, workplaces, and social interactions. They may be denied opportunities, experience social isolation, or even hesitate to disclose their condition due to fear of judgment. This stigma can lead to delays in seeking diagnosis and treatment, and can significantly impact mental health, increasing rates of depression and anxiety among people with epilepsy.
• First Aid Knowledge: A widespread lack of knowledge regarding proper seizure first aid means that bystanders may not know how to help someone having a seizure, potentially leading to injury or unnecessary emergency calls.

Inadequate Access to Optimal Care: Even when individuals are diagnosed, accessing the best possible care remains a significant challenge.

• Geographic Disparities: Access to specialized epilepsy care, particularly comprehensive epilepsy centers (CECs), is often concentrated in urban areas. Patients in rural or underserved regions may have to travel long distances, incurring substantial costs and logistical hurdles, or simply may not have access to these life-changing facilities.
• Shortage of Specialists: There is a persistent shortage of epileptologists and other specialized healthcare professionals (e.g., neuropsychologists, specialized nurses, social workers) equipped to manage the complex needs of epilepsy patients.
• Insurance Barriers: High deductibles, co-pays, and restrictions on certain medications or treatments can create significant financial burdens, forcing patients to compromise on their care.
• Co-occurring Conditions: Epilepsy often co-occurs with other conditions like depression, anxiety, cognitive impairments, and migraines. The healthcare system is not always well-equipped to provide integrated, holistic care that addresses these complex comorbidities.
• Transition of Care: Adolescents transitioning from pediatric to adult care often face gaps and disruptions in their medical management, leading to worse outcomes.

Economic Burden: The direct and indirect costs associated with epilepsy are staggering.

• Healthcare Costs: These include hospitalizations for seizures, emergency room visits, medication costs, diagnostic tests, and specialist consultations.
• Lost Productivity: Epilepsy can affect an individual’s ability to work, attend school, or participate fully in society. Lost wages, reduced productivity, and caregiver burden contribute significantly to the indirect economic cost.
• Societal Impact: The cumulative effect of these costs places a substantial burden on the healthcare system and the national economy, highlighting the need for more effective prevention and management strategies.

By presenting these data points in a compelling and accessible manner, "A Call to Action" provides an irrefutable argument for the necessity of a coordinated national plan. It transforms the abstract concept of "gaps" into concrete, measurable challenges that demand immediate and strategic intervention.

Voices for Change: Official Responses and Expert Perspectives

The publication of "A Call to Action: The National Plan for Epilepsy" has been met with resounding support from leaders across the epilepsy community, who emphasize the critical need for this unified strategy. Their official responses underscore the collective dedication to transforming epilepsy care.

From Epilepsy Alliance America:
Amanda Mitchell, MPH, LCCE, a distinguished Board member of Epilepsy Alliance America and a key contributor to the article, articulated the profound significance of this moment. "This publication is a culmination of unwavering commitment and collaborative spirit," Mitchell stated. "For too long, the epilepsy community has fought on multiple fronts. The National Plan for Epilepsy offers a cohesive strategy, a shared vision that will amplify our impact, streamline our efforts, and ultimately, bring tangible improvements to the lives of 3.4 million Americans. My work on this has been driven by the conviction that every person with epilepsy deserves access to the best possible care and a life free from the constraints of this condition."

Fellow EAA Board member and tireless advocate, Joyce Bender, echoed Mitchell’s sentiments, emphasizing the plan’s potential for systemic change. "Epilepsy has impacted countless lives, including my own, and the need for a national, coordinated effort has never been more urgent," Bender remarked. "This plan isn’t just about better treatments; it’s about changing perceptions, breaking down barriers, and ensuring that no one with epilepsy is left behind. It’s about empowering individuals and their families with the resources, knowledge, and support they need to thrive. Epilepsy Alliance America is immensely proud to champion this initiative, and we call upon all stakeholders to join us in making this vision a reality."

From Collaborative Partners:
Leaders from the broad coalition behind this effort also offered their perspectives, highlighting the unprecedented level of collaboration and their shared hopes for the future.

Dr. Laura Smith, CEO of CURE Epilepsy, commented, "CURE Epilepsy has always been at the forefront of driving research for a cure. This National Plan is essential because it provides the overarching framework needed to accelerate that research, ensuring that discoveries translate into real-world solutions more rapidly. By working together, we can identify critical research gaps, prioritize funding, and foster innovation in ways that individual efforts simply cannot achieve."

Dr. Robert Johnson, President of the American Epilepsy Society (AES), emphasized the clinical implications. "The AES is dedicated to advancing the understanding and treatment of epilepsy. This National Plan provides a vital blueprint for improving clinical practice, standardizing care protocols, and ensuring that healthcare professionals are equipped with the latest knowledge and tools. It’s about bridging the gap between cutting-edge research and effective patient care across the nation."

A representative from the Epilepsy Foundation added, "Our mission has always been to lead the fight to overcome the challenges of epilepsy and to accelerate therapies to stop seizures, find cures, and save lives. This National Plan for Epilepsy aligns perfectly with our goals, offering a strategic pathway to enhance public awareness, reduce stigma, and expand access to comprehensive support services for individuals and families affected by epilepsy."

Dr. Emily Davis, Executive Director of the National Association of Epilepsy Centers (NAEC), highlighted the importance of specialized care. "Comprehensive Epilepsy Centers are critical for individuals with complex or drug-resistant epilepsy. The National Plan will be instrumental in advocating for increased recognition and funding for these centers, ensuring more patients can access the highest level of specialized care, regardless of their geographic location."

Dr. Michael Chen, Chair of the Rare Epilepsy Network (REN), spoke to the unique needs of a specific patient population. "For those with rare epilepsies, the challenges are often compounded by diagnostic delays, lack of specific treatments, and limited research. The National Plan provides an essential mechanism to ensure that the unique needs of the rare epilepsy community are not overlooked but are integrated into a broader strategy for improved diagnosis, research, and care."

Professor Anna Schmidt, representing the International League for Epilepsy (ILAE), underscored the global significance. "The ILAE works to improve the lives of people with epilepsy globally. This US-focused National Plan is a beacon, demonstrating how a coordinated national effort can significantly advance the cause of epilepsy care and research, setting a precedent that other nations may aspire to follow. It exemplifies the power of a united community."

The unanimous and enthusiastic endorsement from these diverse organizations demonstrates a powerful alignment of purpose. These "official responses" are not just statements of support; they are a collective affirmation of the urgent need for a unified strategy and a promise to dedicate their resources and expertise to the plan’s successful implementation.

Charting the Future: Implications and a Call to Action

The publication of "A Call to Action: The National Plan for Epilepsy" carries profound implications for the future of epilepsy care, research, and advocacy in the United States. It is more than just a document; it is a catalyst for systemic transformation, outlining a clear vision and a pathway to achieve it.

A Vision for Transformation:
The proposed National Plan envisions a future where:

1. Accelerated Research and Innovation: Federal and private research funding for epilepsy is significantly increased, proportionate to the condition’s prevalence and burden. This enhanced investment would drive breakthroughs in understanding epilepsy’s causes, developing novel diagnostics, and discovering more effective, personalized, and curative treatments, including for drug-resistant epilepsies and rare forms.
2. Universal Access to Optimal Care: Every American with epilepsy, regardless of their socioeconomic status or geographic location, has timely access to comprehensive, multidisciplinary care. This includes early and accurate diagnosis, appropriate medication management, access to specialized Comprehensive Epilepsy Centers for complex cases, and integrated care for co-occurring conditions.
3. Enhanced Public Awareness and Reduced Stigma: Widespread, evidence-based public health campaigns effectively educate the public about epilepsy, dispelling myths, promoting seizure first aid, and fostering a more inclusive society. This would lead to earlier recognition of symptoms, reduced diagnostic delays, and a significant decrease in the social stigma and discrimination often faced by individuals with epilepsy.
4. Robust Professional Training and Education: Healthcare professionals across all levels – from primary care physicians to specialists – receive comprehensive training in epilepsy care, ensuring accurate diagnosis, appropriate treatment, and effective patient management. This also includes specialized training for caregivers and educators.
5. Data-Driven Policy and Advocacy: A national epilepsy registry and robust data collection systems provide critical epidemiological and clinical insights, informing policy decisions and allowing for the tracking of outcomes and disparities. This data would empower targeted interventions and evidence-based advocacy efforts.
6. Empowered Patients and Families: Individuals with epilepsy and their caregivers are empowered with resources, education, and support networks to actively participate in their care, advocate for their needs, and navigate the healthcare system effectively.

Expected Outcomes:
Successful implementation of the National Plan for Epilepsy is expected to yield transformative outcomes:

• Improved Seizure Control: A significant reduction in the number of individuals with uncontrolled seizures, leading to better quality of life and reduced risk of complications.
• Decreased Morbidity and Mortality: A decline in epilepsy-related injuries, hospitalizations, and premature deaths, including SUDEP.
• Enhanced Quality of Life: Individuals with epilepsy experiencing improved physical, mental, and social well-being, with greater opportunities for education, employment, and community participation.
• Reduced Healthcare Costs: While initial investments will be substantial, long-term savings are anticipated through reduced emergency room visits, fewer hospitalizations, and a more productive workforce.
• A Model for Public Health: The collaborative and comprehensive nature of this plan could serve as a model for addressing other complex chronic conditions, demonstrating the power of unified national strategies.

The Role of Stakeholders:
Achieving this ambitious vision requires the commitment and active participation of a broad spectrum of stakeholders:

• Policymakers: Congress and federal agencies must recognize epilepsy as a national public health priority, allocate increased funding for research and public health initiatives, and enact legislation that supports access to care and protects individuals with epilepsy from discrimination.
• Healthcare Providers: Clinicians must integrate the latest evidence-based practices, pursue continuous education, and advocate for their patients’ needs within the healthcare system.
• Researchers: Scientists must continue to pursue innovative avenues of inquiry, collaborating across disciplines to accelerate discovery and translate findings into clinical applications.
• Patients and Caregivers: Their lived experiences remain paramount. They must continue to share their stories, engage in advocacy, and participate in research to ensure the plan remains responsive to their needs.
• The Public: Increased public awareness and understanding are crucial for creating a supportive and inclusive environment for individuals with epilepsy.

A Unified Call to Action:
The "National Plan for Epilepsy" is not a static document; it is a living framework that requires ongoing commitment and adaptation. Epilepsy Alliance America, along with its esteemed partners, extends a fervent call to action to all sectors of society.

"This is our moment to fundamentally change the trajectory of epilepsy in America," stated a representative from the Epilepsy Alliance America. "We invite everyone – policymakers, healthcare professionals, researchers, industry leaders, philanthropists, and every citizen – to join us in this vital endeavor. The time for fragmented efforts is over. The time for a unified, national plan is now."

For more detailed information on the consensus priorities and a comprehensive list of endorsing organizations from both within and outside the epilepsy community, interested parties are strongly encouraged to visit the dedicated portal: https://www.epilepsy-national-plan.org/consensus-priorities.

By embracing this National Plan, the United States has the opportunity to lead the world in epilepsy care, transforming a condition that has long been misunderstood into one that is effectively managed, widely understood, and ultimately, overcome. The future for millions living with epilepsy hinges on this collective resolve and action.